Evidence map›Paper›PMID 31518364›Full record

Observational studyPloS one2019

The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study.

Raffaele Antonelli Incalzi, Giorgio Walter Canonica, Nicola Scichilone, Sara Rizzoli, Lucia Simoni, Francesco Blasi, STORICO study group

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03105999 (Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03105999 completednot on this map

Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD

TypeobservationalSponsorLaboratori Guidotti S.p.A.Ran2016 to 2018Enrolled683ConditionsChronic Obstructive Pulmonary Disease
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Neurological and Psychiatric Comorbidities in Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease
    Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raffaele Antonelli IncalziUniversity Biomedical Campus of Rome, Rome, Italy.ORCID 0000-0003-2100-2075
Giorgio Walter CanonicaPersonalized Medicine Asthma & Allergy Clinic Humanitas University Humanitas research Hospital, Rozzano, Milan, Italy.
Nicola ScichiloneDIBIMIS, University of Palermo, Piazza delle Cliniche, Palermo, Italy.
Sara RizzoliMedineos Observational Research, Modena, ltaly.
Lucia SimoniMedineos Observational Research, Modena, ltaly.
Francesco BlasiDepartment of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center Fondazione IRCCS Cà Granda Maggiore Hospital, Milan, Italy.ORCID 0000-0002-2285-9970
STORICO study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis paper is aimed to (i) develop an innovative classification of COPD, multi-dimensional phenotype, based on a multidimensional assessment; (ii) describe the identified multi-dimensional phenotypes.

methodsAn exploratory factor analysis to identify the main classificatory variables and, then, a cluster analysis based on these variables were run to classify the COPD-diagnosed 514 patients enrolled in the STORICO (trial registration number: NCT03105999) study into multi-dimensional phenotypes.

resultsThe circadian rhythm of symptoms and health-related quality of life, but neither comorbidity nor respiratory function, qualified as primary classificatory variables. Five multidimensional phenotypes were identified: the MILD COPD characterized by no night-time symptoms and the best health status in terms of quality of life, quality of sleep, level of depression and anxiety, the MILD EMPHYSEMATOUS with prevalent dyspnea in the early-morning and day-time, the SEVERE BRONCHITIC with nocturnal and diurnal cough and phlegm, the SEVERE EMPHYSEMATOUS with nocturnal and diurnal dyspnea and the SEVERE MIXED COPD distinguished by higher frequency of symptoms during 24h and worst quality of life, of sleep and highest levels of depression and anxiety.

conclusionsOur results showed that properly collected respiratory symptoms play a primary classificatory role of COPD patients. The longitudinal observation will disclose the discriminative and prognostic potential of the proposed multidimensional phenotype.

trial registrationTrial registration number: NCT03105999, date of registration: 10th April 2017.

Indexed as

AgedAged, 80 and overAnxietyCircadian RhythmCluster AnalysisCohort StudiesComorbidityCoughDepressionDyspneaFactor Analysis, StatisticalFemaleHumansItalyMaleMemory, Episodic

Identifiers

PMID31518364
PMCPMC6743765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.